Related Experiment Video
Updated: Jan 20, 2026

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint
Haisheng Yang1, Wanqiu Li2, Yingnan Lv1
1School of Public Health, Guangxi Medical University, Nanning 530021, People's Republic of China; Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning 530021, People's Republic of China.
Abstract:
Clear cell renal cell carcinoma (ccRCC) is a highly invasive urological malignant tumor that results in shorter patient survival. At present, the mechanism of ccRCC metastasis is not clear. We explored the possible mechanisms of ccRCC metastasis by analyzing the transcriptome of ccRCC patients from the Cancer Genome Atlas (TCGA) database. Comparing the differences in transcriptome in patients with and without metastasis, we found 323 differential genes (|log2FoldChange| > 1 and P < 0.001). KEGG and GO enrichment analyses of differentially expressed genes (DEGs) suggest that the transfer mechanism of ccRCC may be related to complement and coagulation cascades and cholesterol metabolism. To explore the key genes affecting tumor metastasis, we analyzed the association of these genes with patient survival time and found that 16 genes were significantly associated (P < 0.05). We compared the differences in expression of these 16 genes between ccRCC patients and the normal population, and the results showed that TF and B4GALNT1 were overexpressed in patients. Co-expression gene analysis indicated that TF may participate in the metastasis of cancer through the complement system and mucopolysaccharide biosynthesis. B4GALNT1 may affect metastasis through focal adhesion, calcium signaling pathways, and Hippo signaling pathways. Our studies suggest that the complement system and the coagulation cascade, cholesterol metabolism, calcium pathway and iron transport may be associated in the mechanism of metastasis. TF and B4GALNT1 may be the key genes for metastasis, and they may be potential diagnostic markers and therapeutic targets for ccRCC.
Insights
Investigating clear cell renal cell carcinoma (ccRCC) metastasis revealed key genes TF and B4GALNT1. These genes, linked to complement and cholesterol pathways, may serve as diagnostic markers and therapeutic targets for ccRCC.
Area of Science:
- Urology
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Clear cell renal cell carcinoma (ccRCC) is an aggressive urological cancer with unclear metastatic mechanisms.
- Understanding ccRCC metastasis is crucial for improving patient survival rates.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying ccRCC metastasis.
- To identify key genes and pathways involved in ccRCC progression and metastasis.
Main Methods:
- Transcriptome analysis of ccRCC patients from The Cancer Genome Atlas (TCGA) database.
- Differential gene expression analysis, KEGG and GO enrichment analyses.
- Survival analysis and co-expression gene analysis to identify key metastatic genes.
Main Results:
- Identified 323 differentially expressed genes (DEGs) between metastatic and non-metastatic ccRCC.
- Enrichment analyses suggested roles for complement/coagulation cascades and cholesterol metabolism in ccRCC metastasis.
- TF and B4GALNT1 were identified as key overexpressed genes associated with poor survival, potentially mediating metastasis through complement, focal adhesion, and signaling pathways.
Conclusions:
- The complement system, coagulation cascade, cholesterol metabolism, calcium signaling, and iron transport are implicated in ccRCC metastasis.
- TF and B4GALNT1 represent potential diagnostic markers and therapeutic targets for ccRCC, warranting further investigation.
Related Concept Videos
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
11:27Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
08:39Evaluation of Stem Cell Properties in Human Ovarian Carcinoma Cells Using Multi and Single Cell-based Spheres Assays
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
05:06A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
10:15Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

